NCT01422109

Comparative Pharmacokinetics of YH14659

Comparative Pharmacokinetics After Single Oral Administration of YH14659, a Fixed Dose Combination Versus Coadministration of Separate Constituents in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 44 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to compare pharmacokinetics after single oral administration of 2 capsules of YH14659, a fixed-dose combination of clopidogrel and aspirin developed by Yuhan Corporation versus co-administration of Plavix (clopidogrel) and Astrix (aspirin) in healthy male volunteers.

Conditions

• Acute Coronary Syndrome

Interventions

Type	Name	Description
DRUG	YH14659	YH14659 capsule by oral
DRUG	clopidogrel & aspirin	clopidogrel tablet(75mg) + aspirin capsules(100mg) by oral

Timeline

• Start date: 2011-07-01
• Primary completion: 2011-11-01
• Completion: 2011-12-01
• First posted: 2011-08-23
• Last updated: 2012-01-09

Locations

1 site across 1 country: South Korea